Baker Brothers Life Sciences LP
SEC CIK 1363364 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| KOD | Kodiak Sciences Inc. | Dir, 10% | 18.36M | $87.53M | — | 4 | 2021-09-15 | 2025-12-18 |
| INCY | Incyte | Dir, 10% | 28.19M | — | — | 6 | 2021-12-31 | 2025-06-30 |
| ONC | BeOne Medicines Ltd. | Dir, 10% | 148.1K | — | $392.75M | 3 | 2023-11-14 | 2025-05-21 |
| KNSA | Kiniksa Pharmaceuticals International, plc | Dir | 2.73M | — | — | 1 | 2024-10-04 | 2024-10-04 |
| MDGL | MADRIGAL PHARMACEUTICALS, INC. | Dir | 1.55M | $11.95M | — | 2 | 2023-06-15 | 2023-11-17 |
| NGNE | Neurogene Inc. | Dir, 10% | 481.4K | $1.46M | — | 1 | 2023-08-15 | 2023-08-15 |
Most active insiders at KOD, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Baker Brothers Life Sciences LP | Dir, 10% | $60.00M | — |
| 2 | BORGESON JOHN A. | CFO | — | $2.22M |
| 3 | PERLROTH VICTOR | COB, CEO, Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2025-12-19 | 2025-12-18 | KOD | Kodiak Sciences Inc. | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $23.00 | +2.61M | 18.36M | +17% | +$60.00M |
| MI | 2025-07-02 | 2025-06-30 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +984 | 28.19M | +0.0% | $0 |
| DMI | 2025-06-12 | 2025-06-10 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +5,036 | 28.19M | +0.0% | $0 |
| DMI | 2025-05-22 | 2025-05-21 | ONC | BeOne Medicines Ltd. | Baker Brothers Life Sciences LP | Dir | A - Grant | $0.00 | +43.9K | 148.1K | +42% | $0 |
| MI | 2024-12-10 | 2024-12-09 | ONC | BeOne Medicines Ltd. | Baker Brothers Life Sciences LP | Dir | S - Sale | $187.27 | -1.04M | 9.66M | -10% | -$194.20M |
| DMI | 2024-10-08 | 2024-10-04 | KNSA | Kiniksa Pharmaceuticals International, plc | Baker Brothers Life Sciences LP | Dir | A - Grant | $0.00 | +9,460 | 2.73M | +0.3% | $0 |
| DMI | 2024-05-09 | 2024-05-07 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | M - OptEx | $49.01 | +30.0K | 2.99M | +1% | +$1.47M |
| MI | 2023-11-21 | 2023-11-17+ | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Baker Brothers Life Sciences LP | Dir | P - Purchase | $178.11 | +67.1K | 1.55M | +5% | +$11.95M |
| MI | 2023-11-14 | 2023-11-14 | ONC | BeOne Medicines Ltd. | Baker Brothers Life Sciences LP | Dir, 10% | S - Sale | $180.50 | -1.10M | 877.6K | -56% | -$198.55M |
| MI | 2023-08-17 | 2023-08-15+ | NGNE | Neurogene Inc. | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $0.6395 | +2.29M | 481.4K | New | +$1.46M |
| MI | 2023-07-05 | 2023-06-30 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +1,024 | 2.97M | +0.0% | $0 |
| MI | 2023-06-20 | 2023-06-15 | MDGL | MADRIGAL PHARMACEUTICALS, INC. | Baker Brothers Life Sciences LP | Dir | A - Grant | $0.00 | +9,584 | 1.40M | +0.7% | $0 |
| MI | 2023-01-04 | 2022-12-30 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +794 | 2.95M | +0.0% | $0 |
| MI | 2022-05-18 | 2022-05-16+ | KOD | Kodiak Sciences Inc. | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $5.91 | +456.7K | 1.25M | +58% | +$2.70M |
| MI | 2022-02-17 | 2022-02-15+ | KOD | Kodiak Sciences Inc. | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $54.45 | +401.0K | 14.46M | +3% | +$21.83M |
| MI | 2022-01-04 | 2021-12-31 | INCY | Incyte | Baker Brothers Life Sciences LP | Dir, 10% | A - Grant | $0.00 | +838 | 2.87M | +0.0% | $0 |
| MI | 2021-09-17 | 2021-09-15+ | KOD | Kodiak Sciences Inc. | Baker Brothers Life Sciences LP | Dir, 10% | P - Purchase | $94.39 | +31.8K | 13.30M | +0.2% | +$3.01M |
Purchase Sale Sale after option exercise All abbreviations